Company Filing History:
Years Active: 2023
Title: Ian McNiece: Innovator in Stem Cell Research
Introduction
Ian McNiece is a prominent inventor based in Coral Gables, FL (US). He has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells. His innovative work has the potential to impact various medical treatments and enhance our understanding of multipotential cells.
Latest Patents
Ian McNiece holds a patent for "Bone marrow derived neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells for therapeutic applications." This patent outlines the use of neurokinin 1 receptor (NK1R) as a marker for identifying and isolating multipotential cells. The disclosure provides methods for enriching cell populations and highlights the therapeutic uses of these cells and agents derived from them.
Career Highlights
Ian McNiece is associated with Biocardia, Inc., where he continues to advance his research in stem cell technology. His work focuses on harnessing the potential of NK1R+ mesenchymal stem cells to develop innovative therapeutic solutions.
Collaborations
Ian collaborates with Peter A Altman, leveraging their combined expertise to further their research initiatives.
Conclusion
Ian McNiece's contributions to stem cell research and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to lead to significant breakthroughs in therapeutic applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.